Literature DB >> 21349902

Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease.

Ivana Devic, Hyejin Hwang, John Scott Edgar, Kenneth Izutsu, Richard Presland, Catherine Pan, David R Goodlett, Yu Wang, Jeff Armaly, Vitor Tumas, Cyrus P Zabetian, James B Leverenz, Min Shi, Jing Zhang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21349902      PMCID： PMC3122368          DOI： 10.1093/brain/awr015

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  23 in total

1.  A study of salivary secretion in Parkinson's disease.

Authors:  H Bagheri; C Damase-Michel; M Lapeyre-Mestre; S Cismondo; D O'Connell; J M Senard; O Rascol; J L Montastruc
Journal:  Clin Neuropharmacol       Date:  1999 Jul-Aug       Impact factor: 1.592

2.  Alpha-synuclein immunoreactivity in minor salivary gland biopsies of Parkinson's disease patients.

Authors:  Maria Graciela Cersósimo; Claudia Perandones; Federico Eduardo Micheli; Gabriela Beatriz Raina; Ana Maria Beron; Gustavo Nasswetter; Martin Radrizzani; Eduardo Elias Benarroch
Journal:  Mov Disord       Date:  2010-09-10       Impact factor: 10.338

Review 3.  Parkinson's disease. First of two parts.

Authors:  A E Lang; A M Lozano
Journal:  N Engl J Med       Date:  1998-10-08       Impact factor: 91.245

Review 4.  Salivary glands.

Authors:  A R Silvers; P M Som
Journal:  Radiol Clin North Am       Date:  1998-09       Impact factor: 2.303

5.  Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects.

Authors:  A Bloch; A Probst; H Bissig; H Adams; M Tolnay
Journal:  Neuropathol Appl Neurobiol       Date:  2006-06       Impact factor: 8.090

6.  Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases.

Authors:  K Iwanaga; K Wakabayashi; M Yoshimoto; I Tomita; H Satoh; H Takashima; A Satoh; M Seto; M Tsujihata; H Takahashi
Journal:  Neurology       Date:  1999-04-12       Impact factor: 9.910

Review 7.  Swallowing and esophageal function in Parkinson's disease.

Authors:  B T Johnston; Q Li; J A Castell; D O Castell
Journal:  Am J Gastroenterol       Date:  1995-10       Impact factor: 10.864

8.  Sialochemistry: a diagnostic tool?

Authors:  A Aguirre; L A Testa-Weintraub; J A Banderas; G G Haraszthy; M S Reddy; M J Levine
Journal:  Crit Rev Oral Biol Med       Date:  1993

9.  Intravesicular localization and exocytosis of alpha-synuclein and its aggregates.

Authors:  He-Jin Lee; Smita Patel; Seung-Jae Lee
Journal:  J Neurosci       Date:  2005-06-22       Impact factor: 6.167

10.  Dysautonomia in Parkinsonism: a clinicopathological study.

Authors:  A H Rajput; B Rozdilsky
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-11       Impact factor: 10.154
View more
  80 in total

Review 1.  Biochemical premotor biomarkers for Parkinson's disease.

Authors:  Brit Mollenhauer; Jing Zhang
Journal:  Mov Disord       Date:  2012-04-15       Impact factor: 10.338

Review 2.  Fluid biomarkers for mild traumatic brain injury and related conditions.

Authors:  Henrik Zetterberg; Kaj Blennow
Journal:  Nat Rev Neurol       Date:  2016-09-16       Impact factor: 42.937

Review 3.  Role of cerebrospinal fluid and plasma biomarkers in the diagnosis of neurodegenerative disorders and mild cognitive impairment.

Authors:  Luis F Gonzalez-Cuyar; Joshua A Sonnen; Kathleen S Montine; C Dirk Keene; Thomas J Montine
Journal:  Curr Neurol Neurosci Rep       Date:  2011-10       Impact factor: 5.081

4.  Salivary alpha-synuclein as a biomarker for Parkinson's disease: a systematic review.

Authors:  Anastasia Bougea; Christos Koros; Leonidas Stefanis
Journal:  J Neural Transm (Vienna)       Date:  2019-08-10       Impact factor: 3.575

Review 5.  A deadly spread: cellular mechanisms of α-synuclein transfer.

Authors:  J A Steiner; E Angot; P Brundin
Journal:  Cell Death Differ       Date:  2011-05-13       Impact factor: 15.828

6.  Cheek cell-derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from control.

Authors:  Tessandra Stewart; Yu-Ting Sui; Luis F Gonzalez-Cuyar; David T W Wong; David M Akin; Vitor Tumas; Jan Aasly; Emily Ashmore; Patrick Aro; Carmen Ginghina; Ane Korff; Cyrus P Zabetian; James B Leverenz; Min Shi; Jing Zhang
Journal:  Neurobiol Aging       Date:  2013-09-13       Impact factor: 4.673

7.  Knocking out DJ-1 attenuates astrocytes neuroprotection against 6-hydroxydopamine toxicity.

Authors:  Nirit Lev; Yael Barhum; Tali Ben-Zur; Eldad Melamed; Israel Steiner; Daniel Offen
Journal:  J Mol Neurosci       Date:  2013-03-28       Impact factor: 3.444

Review 8.  Laboratory assessments in the course of Parkinson's disease: a clinician's perspective.

Authors:  Thomas Müller; Horst Baas; Jan Kassubek; Peter Riederer; Peter Paul Urban; Christoph Schrader; Heinz Reichmann; Dirk Woitalla; Manfred Gerlach
Journal:  J Neural Transm (Vienna)       Date:  2015-11-14       Impact factor: 3.575

Review 9.  Is there a need to redefine Parkinson's disease?

Authors:  Philipp Mahlknecht; Werner Poewe
Journal:  J Neural Transm (Vienna)       Date:  2013-05-29       Impact factor: 3.575

10.  Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.

Authors:  Min Shi; Changqin Liu; Travis J Cook; Kristin M Bullock; Yanchun Zhao; Carmen Ginghina; Yanfei Li; Patrick Aro; Romel Dator; Chunmei He; Michael J Hipp; Cyrus P Zabetian; Elaine R Peskind; Shu-Ching Hu; Joseph F Quinn; Douglas R Galasko; William A Banks; Jing Zhang
Journal:  Acta Neuropathol       Date:  2014-07-06       Impact factor: 17.088
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.